Literature DB >> 36185869

A Refractory Case of Amiodarone Thyrotoxicosis.

Marta Fonseca1, Mário Ferreira1, Joana Paulo1, Zélia Neves1.   

Abstract

Amiodarone is frequently used to control cardiac arrhythmias, like atrial fibrillation. Despite its benefits, it has many adverse effects, particularly on the thyroid gland. We describe the case of a patient treated with amiodarone for paroxysmal atrial fibrillation, admitted to the emergency room with atrial fibrillation with a rapid ventricular response. Type II thyrotoxicosis was identified as the cause of the refractory arrhythmia. Since its refractoriness to both pharmacological and electrical therapy, there was a need to proceed with plasmapheresis and total thyroidectomy for hormonal and cardiac rhythm control. Therefore, it is essential to monitor the toxicity of amiodarone, a drug that can have both beneficial and devastating effects.
Copyright © 2022, Fonseca et al.

Entities:  

Keywords:  adverse effects; amiodarone; atrial fibrillation; thyrotoxycosis; toxicity

Year:  2022        PMID: 36185869      PMCID: PMC9516872          DOI: 10.7759/cureus.28527

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

Review 1.  Approach to the patient with amiodarone-induced thyrotoxicosis.

Authors:  Fausto Bogazzi; Luigi Bartalena; Enio Martino
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

2.  2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.

Authors:  Luigi Bartalena; Fausto Bogazzi; Luca Chiovato; Alicja Hubalewska-Dydejczyk; Thera P Links; Mark Vanderpump
Journal:  Eur Thyroid J       Date:  2018-02-14

Review 3.  [Amiodarone effects on thyroid--current concepts].

Authors:  Maria Vítor Campos
Journal:  Acta Med Port       Date:  2004-06-30

4.  Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial.

Authors:  Silvia A Eskes; Erik Endert; Eric Fliers; Ronald B Geskus; Robin P F Dullaart; Thera P Links; Wilmar M Wiersinga
Journal:  J Clin Endocrinol Metab       Date:  2011-11-30       Impact factor: 5.958

Review 5.  Amiodarone and the thyroid.

Authors:  Shehzad Basaria; David S Cooper
Journal:  Am J Med       Date:  2005-07       Impact factor: 4.965

Review 6.  Amiodarone-induced thyroid dysfunction in clinical practice.

Authors:  S Ursella; A Testa; M Mazzone; N Gentiloni Silveri
Journal:  Eur Rev Med Pharmacol Sci       Date:  2006 Sep-Oct       Impact factor: 3.507

7.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

8.  Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update.

Authors:  Luciana Vergara Ferraz de Souza; Maria Thereza Campagnolo; Luiz Claudio Behrmann Martins; Maurício Ibrahim Scanavacca
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

9.  Adverse effects of long-term amiodarone therapy.

Authors:  Hyoung-Seob Park; Yoon-Nyun Kim
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884

10.  Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience.

Authors:  Anupam Kotwal; Jennifer Clark; Melanie Lyden; Travis McKenzie; Geoffrey Thompson; Marius N Stan
Journal:  J Endocr Soc       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.